Results 141 to 150 of about 1,055,712 (266)
Tailoring Magnetic Properties and Power Loss in Low-Temperature Sintered NiCuZn Ferrites with BMLS-CaTiO<sub>3</sub>/BaTiO<sub>3</sub> Composite Additives. [PDF]
Chen C +6 more
europepmc +1 more source
Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin +8 more
wiley +1 more source
A Study on the Effects of Depth-Dependent Power Loss on Speckle Statistics Estimation. [PDF]
Christensen A, Rosado-Mendez I, Hall TJ.
europepmc +1 more source
Diminution of real power loss by novel Galápagos Penguin Algorithm. [PDF]
Kanagasabai L.
europepmc +1 more source
ABSTRACT Objective To determine whether myelin‐sensitive quantitative MRI reveals microstructural abnormalities in normal‐appearing cortex (NACtx) in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), indicating that conventional MRI underestimates remission residual cortical injury.
Valentina Camera +20 more
wiley +1 more source
Optimal placement of distributed generation to minimize power loss and improve voltage stability. [PDF]
Adegoke SA +3 more
europepmc +1 more source
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
Novel empress SARANI optimization algorithm for active power loss reduction and voltage stability enhancement. [PDF]
Kanagasabai L.
europepmc +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source

